ACE 5 Generix C8(2) 4.6 x 150mm

The Avantor ACE Generix C8(2) HPLC column 150x4.6mm, 5µm, is based on an octyl modification (other designations: RP-8, C8) with an adjusted pore structure and higher carbon loading than the classic Generix C8 phase. The Avantor ACE Generix C8(2) offers robust C8 selectivity for reversed-phase methods with good efficiency and reproducible peak shape. It can be used as an alternative when a C8 separation with slightly increased retention or altered selectivity is required. Typical applications are validated HPLC methods, moderately polar active ingredients, quality control, organic impurities and method transfer to modern C8 columns.

Features and Benefits

• High-purity, spherical, and fully base-deactivated silica
• Routine-oriented HPLC phases for validated methods and replacement columns
• Excellent efficiency and symmetrical peaks
• High reproducibility between columns and silica batches
• Individually tested columns with test chromatograms

Additional Information

Avantor ACE Generix is a robust HPLC series designed for routine analysis and cost-effective replacement methods. The base material is high-purity, spherical, fully porous silica with complete base deactivation, which supports reproducible peak shapes for acidic, basic, and neutral analytes. The series focuses on proven reverse-phase selectivities, making it particularly suitable for existing HPLC methods, quality control, and method transfer. Compatible Generix guard cartridges protect the silica matrix of the analytical column from matrix components and can extend the method’s lifespan.

Legal Notices

Avantor ACE is a registered trademark of the manufacturer Avantor, Inc., Radnor, USA.